Abstract
Objectives
To investigate local control and functional outcome following state-of-the-art fractionated stereotactic radiotherapy (FSRT) for paragangliomas of the head and neck.Methods
In total, 40 consecutive patients with paragangliomas of the head and neck received conventionally FSRT from 2003 to 2016 at the Department of Radiation Oncology of the University Hospital Erlangen. Local control, toxicities, and functional outcome were examined during follow-up. In total, 148 magnetic resonance imaging studies were subjected to longitudinal volumetric analysis using whole tumor segmentation in a subset of 22 patients.Results
A total of 80.0% (32/40) of patients received radiotherapy as part of their primary treatment. In 20.0% (8/40) of patients, radiation was used as salvage treatment after tumor recurrence in patients initially treated with surgery alone. The median dose applied was 54.0 Gy (interdecile range, 50.4 to 56.0 Gy) in single doses of 1.8 or 2 Gy. Local control was 100% after a median imaging follow-up of 52.2 months (range, 0.8 to 152.9 mo). The volumetric analysis confirmed sustained tumor control in a subset of 22 patients and showed transient enlargement (range, 129.6% to 151.2%) in 13.6% of cases (3/22). After a median volumetric follow-up of 24.6 months mean tumor volume had diminished to 86.1% compared with initial volume. In total, 52.5% (21/40) of patients reported improved symptoms after radiotherapy, 40% (16/40) observed no subjective change with only 7.5% (3/40) reporting significant worsening.Conclusions
State-of-the-art FSRT provides excellent control and favorable functional outcome in patients with paragangliomas of the head and neck. The volumetric analysis provides improved evidence for sustained tumor control.Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1097/coc.0000000000000614
Article citations
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy".
Strahlenther Onkol, 200(1):1-18, 02 Jan 2024
Cited by: 2 articles | PMID: 38163834 | PMCID: PMC10784363
Review Free full text in Europe PMC
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy.
Cancers (Basel), 14(6):1547, 17 Mar 2022
Cited by: 1 article | PMID: 35326697 | PMCID: PMC8946188
FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
Front Oncol, 10:559193, 30 Sep 2020
Cited by: 22 articles | PMID: 33102223 | PMCID: PMC7554610
Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential.
Int J Mol Sci, 21(23):E9321, 07 Dec 2020
Cited by: 12 articles | PMID: 33297429 | PMCID: PMC7730287
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.
Head Neck, 36(1):22-27, 04 May 2013
Cited by: 7 articles | PMID: 23649985
Paraganglioma of the head and neck: long-term local control with radiotherapy.
Am J Clin Oncol, 32(3):304-307, 01 Jun 2009
Cited by: 26 articles | PMID: 19433962
Robotic radiosurgery of head and neck paragangliomas: a single institution experience.
Asia Pac J Clin Oncol, 14(2):e3-e7, 24 May 2017
Cited by: 2 articles | PMID: 28544809
Treatment of paragangliomas with radiation therapy.
Otolaryngol Clin North Am, 34(5):1007-20, vii-viii, 01 Oct 2001
Cited by: 17 articles | PMID: 11557452
Review
Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
Head Neck, 39(3):595-601, 20 Dec 2016
Cited by: 24 articles | PMID: 27997054
Review